The Russian Ministry of Health has registered a new drug for the treatment of Covid, Ambervin, and included in the Ministry of Health registry.
"Treatment of a new moderate-to-severe coronavirus infection as part of the complex therapy of viral lung lesions," the prescription reads. The drug is used intramuscularly and through inhalation.













